The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif
Science Signaling · 2023
DOI: 10.1126/scisignal.adg2610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2023. Verfasst von Katharina Aigner-Radakovics und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria. Hauptthemen laut MEDLINE: Antigens, CD, Lymphocyte Activation Gene 3 Protein, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Lymphocyte activation gene 3 (LAG3) is an inhibitory immune checkpoint receptor that restrains autoimmune and antitumor responses, but its evolutionarily conserved cytoplasmic tail lacks classical inhibitory motifs. Major histocompatibility complex class II (MHC class II) is an established LAG3 ligand, and fibrinogen-like protein 1 (FGL1), lymph node sinusoidal endothelial cell C-type lectin (LSECtin), and Galectin-3 have been proposed as alternative binding partners that play important roles in LAG3 function. Here, we used a fluorescent human T cell reporter system to study the function of LAG3. We found that LAG3 reduced the response to T cell receptor stimulation in the presence of MHC class II molecules to a lesser extent compared with the receptor programmed cell death protein 1. Analysis of deletion mutants demonstrated that the RRFSALE motif in the cytoplasmic tail of LAG3 was necessary and sufficient for LAG3-mediated inhibition. In this system, FGL1, but not LSECtin or Galectin-3, acted as a LAG3 ligand that weakly induced inhibition. LAG3-blocking antibodies attenuated LAG3-mediated inhibition in our reporter cells and enhanced reporter cell activation even in the absence of LAG3 ligands, indicating that they could potentially enhance T cell responses independently of their blocking effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria.
- Christian Doppler Laboratory for Next Generation CAR T Cells, Vienna, Austria.
- St. Anna Children's Cancer Research Institute, Vienna, Austria.
- Institute of Plant Biotechnology and Cell Biology (IPBT), Department of Applied Genetics and Cell Biology (DAGZ), University of Natural Resources and Life Sciences Vienna (BOKU), Vienna, Austria.
- Karl Landsteiner University, Krems, Austria.
ORCID-Profile: Katharina Aigner-Radakovics, Benjamin Salzer, Manfred Lehner, Shiva Izadi, Alexandra Castilho, Winfried F Pickl, Judith Leitner, Peter Steinberger
Zitieren
APA
Aigner-Radakovics, K., De Sousa Linhares, A., Salzer, B., Lehner, M., Izadi, S., Castilho, A., Pickl, W. F., Leitner, J., & Steinberger, P. (2023). The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif. Science Signaling. https://doi.org/10.1126/scisignal.adg2610
Vancouver
Aigner-Radakovics K, De Sousa Linhares A, Salzer B, Lehner M, Izadi S, Castilho A, et al. The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif. Science Signaling. 2023. doi:10.1126/scisignal.adg2610
BibTeX
@article{AignerRadakovics2023,
author = {Aigner-Radakovics, Katharina and De Sousa Linhares, Annika and Salzer, Benjamin and Lehner, Manfred and Izadi, Shiva and Castilho, Alexandra and Pickl, Winfried F and Leitner, Judith and Steinberger, Peter},
title = {The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif},
journal = {Science Signaling},
year = {2023},
doi = {10.1126/scisignal.adg2610}
}
EUVIMED